TSC-36 Antibodies

Santa Cruz Biotechnology delivers a wide array of Tsc-36 monoclonal antibodies for research applications. Tsc-36 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tsc-36, also known as Tuberous Sclerosis Complex 2 (TSC2), plays a critical role in regulating cell growth and proliferation by inhibiting the mTOR signaling pathway. Tsc-36 maintains cellular homeostasis and has been linked to various conditions, including tuberous sclerosis and certain types of cancer. Research focused on Tsc-36 continues to reveal new insights about its role in cellular processes and disease development. Scientists worldwide are actively studying Tsc-36 to better understand its functions and potential therapeutic applications. Understanding Tsc-36 mechanisms can lead to improved treatment strategies for related medical conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic solutions for Tsc-36-related disorders.